EGFR-mutated lung cancer: treatment with osimertinib alone — what this means today | Dr Dilanka De Silva
Who this is for If you have been told your lung cancer has an EGFR mutation and are trying to
Dr Dilanka De Silva
EGFR-mutated lung cancer: newer treatment strategies — does adding chemotherapy improve survival? | Dr Dilanka De Silva
Who this is for If you have EGFR-mutated lung cancer and have been told about newer treatment approaches — including
ALK-positive lung cancer: “Death sentence” narrative 15 years ago to “chronic disease management” | Dr Dilanka De Silva
Who this is for If you or someone close to you has been diagnosed with ALK-positive lung cancer and you
Why hormone therapy stops working after CDK4/6 — and what we do instead | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer whose cancer
Lifting the Tail: How Immunotherapy Changed Long-Term Survival in Advanced Cancer | Dr Dilanka De Silva
Who this is for: People diagnosed with advanced cancer — including melanoma, lung cancer, kidney cancer, or bile duct cancer
Early breast cancer in Melbourne: how treatment decisions are made today | Dr Dilanka De Silva
Who this is for This page is for people who have recently been diagnosed with early-stage breast cancer — cancer
Advanced bile duct cancer (cholangiocarcinoma): how immunotherapy changed survival (TOPAZ-1) | Dr Dilanka De Silva
Who this is for: People with advanced bile duct cancer (cholangiocarcinoma, gallbladder cancer, or other biliary tract cancers) who want
TAILORx: when chemotherapy can safely be avoided in early breast cancer | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative early breast cancer who have been told
Why lymph node–positive breast cancer is not all the same | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative early breast cancer who have been told
Advanced breast cancer treatment in Melbourne: what happens after CDK4/6 inhibitors stop working | Dr Dilanka De Silva
Who this is for This page is for people with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer whose cancer